Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Editorial [ Hot Topic: Drugs Targets in Parkinson's Disease:Where Are We and Where should We Go? (Guest Editor: Mark R. Cookson)]

Author(s): Mark R. Cookson

Volume 10, Issue 6, 2011

Page: [650 - 650] Pages: 1

DOI: 10.2174/187152711797247830

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

12

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment
Current Pharmaceutical Design

Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
Current Neuropharmacology

α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science

Age-related Changes in Pharmacodynamics: Focus on Drugs Acting on Central Nervous and Cardiovascular Systems
Current Drug Metabolism

Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs
Current Drug Targets

Leukopenia Associated with Risperidone Treatment
Current Drug Safety

Neural Stem Cells Transplanted in a Mouse Model of Parkinson’s Disease Differentiate to Neuronal Phenotypes and Reduce Rotational Deficit
CNS & Neurological Disorders - Drug Targets

Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry

Past, Present and Future Therapeutics for Cerebellar Ataxias
Current Neuropharmacology

Regulation of Postsynaptic Stability by the L-type Calcium Channel Ca<sub>V</sub>1.3 and its Interaction with PDZ Proteins
Current Molecular Pharmacology

PET Imaging in Parkinsons Disease
Current Medical Imaging

New Insights on Dimethylaminoethanol (DMAE) Features as a Free Radical Scavenger
Drug Metabolism Letters

Selected Natural and Synthetic Agents Effective against Parkinson’s Disease with Diverse Mechanisms
Current Topics in Medicinal Chemistry

Antipsychotics in Obsessive-Compulsive Disorder
Current Psychiatry Reviews

9th International Meeting on Metabotropic Gglutamate Receptors (Taormina, Sicily, October 1-6, 2017).
Current Neuropharmacology

AMPA Receptor Potentiators: Application for Depression and Parkinsons Disease
Current Drug Targets

L-DOPA and Serotonergic Neurons: Functional Implication and Therapeutic Perspectives in Parkinson's Disease
Central Nervous System Agents in Medicinal Chemistry

Machine Learning, Molecular Modeling, and QSAR Studies on Natural Products Against Alzheimer’s Disease
Current Medicinal Chemistry

A2A Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry

Substance Abuse and Movement Disorders
Current Drug Abuse Reviews

© 2025 Bentham Science Publishers | Privacy Policy